DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-71.62%
US · US
FISV.US latest organized financial period shows revenue grew +3.6% YoY and net income grew +11.15% YoY. Current price is about 61.41 USD, while the model base case is about 216 USD; the current price sits -71.6% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:28
Hover each model row to inspect formulas and inputs.
-71.62%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-71.62%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
-73.74%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -7.5% annualized FCF growth.
Estimates earnings power value without assuming growth.
-31.06%
Updated: 2026/04/29 15:28
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2022/12/31 | Asset impairment | Impairment | -22M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -36M USD | Medium |
| 2021/12/31 | Integration and restructuring costs | Restructuring | -186M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -294M USD | Medium |
| 2020/12/31 | Business sale gain/loss | Asset sale gain/loss | 733M USD | Medium |
| 2020/12/31 | Integration and restructuring costs | Restructuring | -718M USD | Medium |
| 2024/09/30 | Asset impairment | Impairment | -11M USD | Medium |
| 2024/06/30 | Asset impairment | Impairment | -11M USD | Medium |
| 2024/03/31 | Asset impairment | Impairment | -11M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 21B USD | 3B USD | - | 4B USD | 6.34 | - |
| 2024/12/31 | Annual | 20B USD | 3B USD | - | 5B USD | 5.38 | - |
| 2023/12/31 | Annual | 19B USD | 3B USD | - | 4B USD | 4.98 | - |
| 2022/12/31 | Annual | 18B USD | 3B USD | 3B USD | 3B USD | 3.91 | 3.94 |
| 2021/12/31 | Annual | 16B USD | 1B USD | 2B USD | 3B USD | 1.99 | 2.32 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/15 - 2026/04/29.